SureTrader Nadex Advertisement SureTrader
Home > Boards > US Listed > Medical - Equipment >

InspireMD, Inc. (NSPR)

NSPR RSS Feed
Add NSPR Price Alert      Hide Sticky   Hide Intro
Moderator: Value_Investor
Search This Board: 
Last Post: 4/22/2017 8:05:59 AM - Followers: 51 - Board type: Free - Posts Today: 0

 


 

Company

 

InspireMD was founded in 2005 with the purpose of creating a technology that could solve the problem of embolization in high risk vascular procedures. The company has grown to include a portfolio of embolic protection systems, which it both manufactures and commercializes.

Today, InspireMD is a global company headquartered in Boston, MA. InspireMD seeks to utilize its proprietary MicroNetTM technology to make its products the industry standard for embolic protection by providing a superior solution to the key clinical issues of vascular procedures.
 

Our Technology

 

MicroNetTM

The MicroNet is a bio-stable mesh woven from a single strand of 20 μm Polyethylene Terephthalate (PET). The MicroNet is designed to trap and seal thrombus and plaque against the vessel wall, preventing embolization.

MicroNetTM key features:

  • PET is a bio-stable synthetic fiber widely used in a variety of industries.
    Attached and secured to the proximal and the distal crowns of the stent.
    Does not alter the procedure as it expands with the stent.
    Pore size is typically between 150 – 180 µm.
     
     

CGuard™

 

cgaurd  

v

Dual Layer Design

Open cell stent platform wrapped in MicroNet mesh

MicroNetTM v

For continuous embolic prevention

v

SmartFitTM Technology

Eliminates need for tapered version


Carotid Embolic Prevention System

The CGuardTM Embolic Prevention System (EPS) is designed to prevent peri-procedural and late embolization by trapping potential emboli against the arterial wall while maintaining excellent perfusion to the external carotid artery and branch vessels.

 

Product Details:

  • CGuard material: Nitinol

MicroNet material: Polyethylene Terephthalate (PET)
  • Easy to use RX (Rapid Exchange) delivery system

     

MGuard™

Expand_s003.small  

vMicroNetTM Technology

For continuous embolic protection

Proven Safety and Efficacyv

Used in thousands of patients

v

Strut Thickness

100 microns


Improving Clinical Outcomes For STEMI Patients

The MGuardTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization and optimize flow.

While offering performance that is superior to standard STEMI therapy, MGuard requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard material: Stainless Steel 316
 
  • MicroNet material: Polyethylene Terephthalate (PET)

     

MGuard Prime™

 

MGuard-Prime-e1407751799122  

v

MicroNetTM Technology

For continuous embolic protection

Cobalt Chromiumv

Highly biocompatible

v

Strut Thickness

80 microns


Improving Clinical Outcomes For STEMI Patients

The MGuard PrimeTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization, and optimize flow, while ensuring excellent deliverabililty.

While offering performance that is superior to standard STEMI therapy, MGuard Prime requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard Prime material: Cobalt Chromium (CoCr) L605

MicroNet material: Polyethylene Terephthalate (PET)
  • Superior flexibility and excellent deliverability

http://www.inspiremd.com/en/products/the-technology/

 

2017 News

Thursday23March 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at ICCA Stroke 2017 in Moscow, Russia

BOSTON, MA—March 23, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS), neurovascular devices and thrombus management technologies, today announced that its…

Wednesday22March 2017

InspireMD Repays Term Note Ahead of Schedule

Tel Aviv—March 22, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that…

Tuesday21March 2017

InspireMD Announces Distribution Agreement for CGuard™ EPS in Hong Kong

BOSTON, MA—March 21, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Monday20March 2017

InspireMD Announces CGuardTM Distribution Agreement for the Russian Federation

Tel Aviv—March 20, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Wednesday15March 2017

InspireMD Reports Continued Progress in the Transition of European Sales and Distribution

Announces Agreements with Leading Distributors in the Baltic States   BOSTON, MA—March 15, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS)…

Tuesday14March 2017

InspireMD Announces Closing of Public Offering of Approximately $6.8 Million

BOSTON, MA – March 14, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday09March 2017

InspireMD Announces Pricing of Public Offering of up to $7.5 Million

BOSTON, MA – March 9, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday16February 2017

InspireMD Provides Year End Business Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016

Transition from Exclusive Distribution Partner to Local Distributors and Internal Sales Strategy Validated by Strong Revenue Growth in Select Markets   BOSTON, MA—February 16, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS)…

Tuesday24January 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at LINC 2017

PD Dr. Andrej Schmidt to perform live case transmission of carotid stent surgery utilizing CGuard™ BOSTON, MA– January 24, 2016 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a…

Contact Us

 

Thank you for your interest in InspireMD, please let us know how we can help you. You can contact us at info@inspiremd.com or 1-888-776-6804.

 

map

Executives

 

board_jb-02
James J. BarryPresident & Chief Executive Officer

Dr. Barry has over 20 years of experience in the medical device industry. Prior to joining InspireMD, he was the President and CEO of Arsenal Medical, a life sciences company…

exe_shore
Craig ShoreChief Financial Officer

Mr. Shore has over 25 years of experience in financial management in the United States, Europe and Israel. He has served in various senior financial and general management roles at…

image002_web
Agustin GagoExecutive Vice President and Chief Commercial Officer

Mr. Gago has over 25 years of experience in building profitable international commercial, sales and marketing organizations. Prior to joining InspireMD, he was the founder and principal of Dash International…

20161102_191058_web
Benzi SpectorHead of R&D and Operations

Mr. Spector has more than 25 years of experience in research, development and engineering, serving as the lead on a range of product lines and systems in the healthcare space….

20161106_103740_web
Sharon ShacharHead of Regulatory and Quality

Mrs. Shachar has over 12 years of experience in quality, regulatory and clinical execution, serving in executive roles in small and large medical companies.   Prior to joining InspireMD, she…



Website
http://www.inspiremd.com/en/




     
  •  
     
     

  •  


 


 

 

 

      
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NSPR
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PostSubject
#761  Sticky Note The CEO should issue some Great news to Value_Investor 04/12/17 11:01:42 AM
#780   revenue news from the newly est. relationships will bill_y 04/22/17 08:05:59 AM
#779   $2.74 (which is 4.55 Times of the Bottom) Value_Investor 04/21/17 03:56:33 PM
#778   I like this company, reasons to enter? $NSPR pennystock_es 04/21/17 03:53:07 PM
#777   Should the company do a F/S then NSPR Value_Investor 04/21/17 03:25:12 PM
#776   Just bought back at 0.635 some of the Rymankoly 04/21/17 01:47:50 PM
#775   Needs liquidity, since they wiped those undesirable investors Wildbilly 04/21/17 12:10:15 PM
#774   Just two days ago NSPR hit the new Value_Investor 04/21/17 10:16:55 AM
#773   NSPR is Hyper Oversold now --- from $4.39 Value_Investor 04/20/17 11:57:43 PM
#772   This is thing needs to go up, no speedstar 04/20/17 09:10:18 PM
#771   Nice to see this hidden gem closed at Value_Investor 04/17/17 06:00:24 PM
#770   5,000 shares bought at $0.75 (Up 13.5% from Value_Investor 04/13/17 08:15:36 PM
#769   that is incorrect the new stent is not bill_y 04/13/17 06:43:54 PM
#768   NSPR hit the New high $0.75 in Pre-Market Value_Investor 04/13/17 11:09:02 AM
#767   this new local marketing strategy seems the only bill_y 04/12/17 07:18:09 PM
#766   if they begin to see significant revenues from bill_y 04/12/17 06:48:36 PM
#765   Yes. With any good news from the company Value_Investor 04/12/17 06:01:11 PM
#764   They are done completely which is why today Value_Investor 04/12/17 04:34:54 PM
#763   Looks like that seller's gone! paideia 04/12/17 03:31:09 PM
#762   For whatever reason, some large seller seems to paideia 04/12/17 02:53:53 PM
#761   The CEO should issue some Great news to Value_Investor 04/12/17 11:01:42 AM
#760   I don't care the warrants at all unless Value_Investor 04/12/17 10:30:17 AM
#759   seems the warrants were up 20% yesterday..or was bill_y 04/12/17 07:46:25 AM
#758   The company just need to issue a similar Value_Investor 04/11/17 09:13:24 PM
#757   100% manipulation! Just a few months ago NSPR Value_Investor 04/10/17 01:23:24 PM
#756   I've seen it happen and it sucks to CIMA7 04/10/17 12:12:08 PM
#755   Yes. The current warrant B&C can only be Value_Investor 04/10/17 12:06:18 PM
#754   I'm very glad to take my first position Value_Investor 04/10/17 12:03:17 PM
#753   share price is being managed down..these guys may bill_y 04/09/17 09:24:20 AM
#752   Are you sure there's no adjustment clause in CIMA7 04/08/17 10:20:13 PM
#751   Ok, your source link can beat up my Wildbilly 04/08/17 07:47:47 AM
#750   Also the Positive Book Value per share from Value_Investor 04/07/17 06:47:34 PM
#749   stockcalc.com agrees with Yahoo Wildbilly 04/07/17 06:41:13 PM
#748   Is the Cash Value per share at $5.40 Value_Investor 04/07/17 06:27:32 PM
#747   Anything is possible, especially with that crazy share structure. Wildbilly 04/07/17 02:16:30 PM
#746   If the company could issue some similar great Value_Investor 04/07/17 01:45:17 PM
#745   Are you sure those warrant at $2.00 per Value_Investor 04/07/17 01:23:20 PM
#744   Yes, what's 70 cents a share? Wait, it JenningsB 04/07/17 01:06:00 PM
#743   Why? Fortunately I got rid of this pos Value_Investor 04/07/17 01:03:50 PM
#742   Mon April 10, Series B warrants to commence Wildbilly 04/07/17 11:34:42 AM
#741   feels like an acquisition strategy..the warrants go on bill_y 04/06/17 07:38:30 PM
#740   Apparently any news makes this go down. porgyrusty 04/06/17 04:01:19 PM
#739   Good news for NSPR today --- see the Value_Investor 04/06/17 08:37:18 AM
#738   I still think this is a good swing. jones99 04/05/17 04:52:50 AM
#737   Starting out positive in premarket! Doc Hollywood 03/31/17 08:22:10 AM
#736   Where do you see it going? speedstar 03/30/17 07:47:34 PM
#735   * * $NSPR Video Chart 03-30-17 * * ClayTrader 03/30/17 06:03:51 PM
#734   It still is going up bit by bit. Doc Hollywood 03/30/17 01:18:33 PM
#733   Got in at 1.00!! QUANTUM314 03/30/17 01:14:29 PM
#732   And volume picking up! Hopefully it'll keep the Sasquatch81 03/30/17 12:58:42 PM
#731   Back to one dollar finally!! Doc Hollywood 03/30/17 12:51:18 PM
PostSubject